Whitehawk Therapeutics (WHWK) Net Income Growth (5y) (2015 - 2026)

Whitehawk Therapeutics (WHWK) Net Income Growth (5y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Whitehawk Therapeutics 256.87 Mn 45.62 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -32.30%
Dec 31, 2025 -41.41%
Sep 30, 2025 -44.53%
Jun 30, 2025 -54.13%
Mar 31, 2025 80.36%
Dec 31, 2024 -25.87%
Sep 30, 2024 -18.58%
Jun 30, 2024 -19.44%
Mar 31, 2024 -15.77%
Dec 31, 2023 -12.55%
Sep 30, 2023 -29.34%
Jun 30, 2023 -15.27%
Mar 31, 2023 -8.53%
Dec 31, 2022 -9.04%
Sep 30, 2022 -10.93%
Jun 30, 2022 -16.41%
Mar 31, 2022 -12.13%
Dec 31, 2021 -37.04%
Sep 30, 2021 -78.93%
Jun 30, 2021 18.91%